Form 4 for PRAX Praxis Precision Medicines, Inc.
Accepted 2024-07-31 00:00:00 ET · period of report 2024-07-29 · accession 0001104659-24-084505 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-31 | 2024-07-29 | PRAX | Nemiroff Alex | GC, Sec | A - Grant | $0.00 | +7,800 | 11.0K | +247% | $0 |
| D | 2024-07-31 | 2024-07-29 | PRAX | Nemiroff Alex | GC, Sec | A - Grant | $0.00 | +36.4K | 36.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-29 | A | A | 7,800 | $0.00 | 10,957 | D | — | — | (F1) Mr. Nemiroff was awarded 7,800 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 12, 2025, subject to the reporting person's continued service through each vesting date. The restricted stock units have no expiration date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-07-29 | A | A | 36,400 | $0.00 | 36,400 | D | $56.94 · — to 2034-07-29 | 36,400 Common Stock | (F2) The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date. |